Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/28/2025

Low Potency Topical Corticosteroids

Classification and Clinical Applications

  • The American Academy of Dermatology recommends low potency topical corticosteroids, such as hydrocortisone 1-2.5%, desonide 0.05%, fluocinolone acetonide 0.01%, and alclometasone dipropionate 0.05%, for use on sensitive areas like the face, genitals, and intertriginous areas 1
  • Low potency topical corticosteroids are classified as Class VI (Low potency) and Class VII (Lowest potency), with examples including fluocinolone acetonide 0.01% and hydrocortisone 1-2.5%, respectively 2
  • The American Academy of Dermatology suggests that low potency topical corticosteroids, such as desonide 0.05% and alclometasone dipropionate 0.05%, are useful for mild inflammatory skin conditions, particularly in areas prone to steroid-induced atrophy 4
  • Low potency topical corticosteroids are indicated for sensitive anatomical areas, such as the face, neck, intertriginous areas, and genitals, due to their lower risk of adverse effects 2, 1
  • The American Academy of Dermatology recommends hydrocortisone 1-2.5% for mild inflammatory conditions, especially on the face, and fluocinolone acetonide 0.01% for mild scalp psoriasis and facial dermatoses 5, 8
  • Alclometasone dipropionate 0.05% is suitable for facial application in conditions like atopic dermatitis, according to the Journal for ImmunoTherapy of Cancer 4
  • The BMJ suggests that low potency topical corticosteroids, such as hydrocortisone 1-2.5%, are effective for mild atopic dermatitis, especially for facial involvement 6, 7

Pharmacology and Safety Profile

  • No cited facts are available for this section

Application Guidelines

  • The American Academy of Dermatology recommends applying low potency topical corticosteroids once or twice daily as directed, with no specified time limit for use 2

Common Pitfalls and Caveats

  • Inappropriate potency selection, such as using low potency steroids for conditions requiring higher potency, can lead to inadequate response, according to the American Academy of Dermatology 1, 3

REFERENCES